Making a difference by speaking out: Jeff wigand says exactly what's on his mind

Journal of Management Inquiry

Volumn 13, Issue 4, 2004, Pages 355-362

  Armenakis, Achilles ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Ethics; The insider; Tobacco; Whistle blower

Indexed keywords

EID: 10244229757     PISSN: 10564926     EISSN: None     Source Type: Journal    
DOI: 10.1177/1056492604270800     Document Type: Review

References (12)

1. Alford, F. (2001). Whistleblowers: Broken lives and organizational power. Ithaca, NY: Cornell University Press.
2. Department of Justice. (1998, January 23). Plant company pleads guilty in tobacco fraud investigation [Press release]. Available at www.usdoj.gov/opa/pr/1998/January/ 020.htm
3. Kant, I. (1983). Ethical philosophy: The complete texts of grounding for the metaphysics of morals, metaphysical principles of virtue, and Part II of the metaphysics of morals (J. W. Ellington, Trans.). Indianapolis, IN: Hackett.
4. Kessler, D. (2001). A question of intent: A great American battle with a deadly industry. New York: Public Affairs.
5. Meier, B. (1998, January 8). U.S. brings first charges in inquiry on tobacco companies. The New York Times, p. A16.
6. Miethe, T. (1999). Whistleblowing at work. Boulder, CO: Westview.
7. Mollenkamp, C., Levy, A., Menn, J., & Rothfeder, J. (1998). The people vs. big tobacco: How the states took on the cigarette giants. Princeton, NJ: Bloomberg.
8. National Institutes of Health. (1993, September). Toxicology and carcinogenesis studies of coumarin (NTP TR 422, NIH No. 93-3153). Research Triangle Park, NC: National Toxicology Program.
9. Rawls, J. (1999). Collected papers (S. Freeman, Ed.). Cambridge, MA: Harvard University Press.
10. Sapsford, J., & Beckett, P. (2002, November 25). The complex goals and unseen costs of whistle-blowing. The Wall Street Journal, 240(104), A-1, A-10.
11. Statement of David Goerlitz. Hearings before the Subcommittee on Transportation and Hazardous Materials of the Committee on Energy and Commerce, House of representatives, 101st Congress, First Session including H.R. 1250, 41 (1989, September 13) (Testimony of David Goerlitz).
12. Weinstein, H. (1998, January 8). U.S. accuses company of high-nicotine plot; Law: First criminal case claims biotech firm conspired with cigarette maker to grow plant with increased levels. Los Angeles Times, (GENTECH archive 9.96-97, pp. 1-5).